Showing results (191-200 of 201) with videos related to
Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituentK Dinnell, G G Chicchi, M J Dhar, et al.Journal of Occupational and Environmental Medicine|February 2, 2018
Measuring Best Practices for Workplace Safety, Health, and Well-Being: The Workplace Integrated Safety and Health AssessmentGlorian Sorensen, Emily Sparer, Jessica A R Williams, et al.British Journal of Cancer|February 1, 1996
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancerJ M Bartlett, S P Langdon, B J Simpson, et al.Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitutionL C Cooper, G G Chicchi, K Dinnell, et al.Transboundary and Emerging Diseases|November 11, 2017
Mind the gaps in research on the control of gastrointestinal nematodes of farmed ruminants and pigsJ Charlier, S M Thamsborg, D J Bartley, et al.European Journal of Pharmacology|May 20, 1997
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonistsN M Rupniak, F D Tattersall, A R Williams, et al.Journal of Medicinal Chemistry|November 7, 1998
Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonistJ J Hale, S G Mills, M MacCoss, et al.Scientific Reports|June 12, 2015
Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparumM C Kapulu, D F Da, K Miura, et al.Journal of Medicinal Chemistry|March 29, 2000
Phosphorylated morpholine acetal human neurokinin-1 receptor antagonists as water-soluble prodrugsJ J Hale, S G Mills, M MacCoss, et al.Science (New York, N.Y.)|September 11, 1998
Distinct mechanism for antidepressant activity by blockade of central substance P receptorsM S Kramer, N Cutler, J Feighner, et al.Pageof 21